Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Suter

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Virology|October 10, 2014
Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responsesMichael Wolferstätter, Marc Schweneker, Michaela Späth, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memoryMaria Hinterberger, Raphael Giessel, Giovanna Fiore, et al.
Frontiers in Immunology|February 9, 2018
NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding FlagellinStephanie L Sanos, Ronny Kassub, Marco Testori, et al.
Nature Communications|November 8, 2019
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodiesJosé Medina-Echeverz, Maria Hinterberger, Marco Testori, et al.
Journal of Virology|March 24, 2017
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like ParticlesMarc Schweneker, Andrea S Laimbacher, Gert Zimmer, et al.
The Journal of Experimental Medicine|October 27, 2010
Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly ICHenning Lauterbach, Barbara Bathke, Stefanie Gilles, et al.
Science (New York, N.Y.)|July 24, 2012
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modificationMarina Oldenburg, Anne Krüger, Ruth Ferstl, et al.
Frontiers in Immunology|February 23, 2026
MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responsesStephan Rambichler, Ronny Kassub, Rodrigo Carrasco-León, et al.
The Journal of Clinical Investigation|May 18, 2018
Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumoniaOliver H Robak, Markus M Heimesaat, Andrey A Kruglov, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Virology|October 10, 2014
Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responsesMichael Wolferstätter, Marc Schweneker, Michaela Späth, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memoryMaria Hinterberger, Raphael Giessel, Giovanna Fiore, et al.
Frontiers in Immunology|February 9, 2018
NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding FlagellinStephanie L Sanos, Ronny Kassub, Marco Testori, et al.
Nature Communications|November 8, 2019
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodiesJosé Medina-Echeverz, Maria Hinterberger, Marco Testori, et al.
Journal of Virology|March 24, 2017
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like ParticlesMarc Schweneker, Andrea S Laimbacher, Gert Zimmer, et al.
The Journal of Experimental Medicine|October 27, 2010
Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly ICHenning Lauterbach, Barbara Bathke, Stefanie Gilles, et al.
Science (New York, N.Y.)|July 24, 2012
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modificationMarina Oldenburg, Anne Krüger, Ruth Ferstl, et al.
Frontiers in Immunology|February 23, 2026
MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responsesStephan Rambichler, Ronny Kassub, Rodrigo Carrasco-León, et al.
The Journal of Clinical Investigation|May 18, 2018
Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumoniaOliver H Robak, Markus M Heimesaat, Andrey A Kruglov, et al.
Pageof 4